Home/ Stocks/ LONA

LeonaBio, Inc. Common Stock

LONA XNAS

$10.04 +0.18 (+1.83%) ▲ 15-min delayed

Open

$9.85

High

$10.46

Low

$9.07

Volume

80.9K

Market Cap

$94.31M

About LeonaBio, Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 19 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-32,948,000	$-1.73
TTM	$0	$-129,414,000	$-22.49

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for LONA yet. Check out our latest market news or earnings calendar.

Get LONA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on LeonaBio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.